Publication: Impact of covid-19 pandemic on nationwide antidiabetic drug utilization
No Thumbnail Available
Date
2023-05-16
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Introduction
The COVID-19 pandemic resulted in various outcomes that have altered disease
prevalence and drug utilization patterns. Our study aimed to evaluate the trends in
the utilization and costs of antidiabetic medications before and during the
COVID-19 outbreak in Turkey.
Methods
We obtained nationwide sales data for antidiabetics from IQVIA Turkey,
spanning between April 2018 and March 2022. Mean monthly drug utilization
and expenditure trends before the pandemic (April 2018-March 2020) and during
the pandemic (April 2020-March 2022) were compared. Drug utilization was
measured by defined daily dose/1000 inhabitants/day (DID) unit.
Results
Utilization of antidiabetic drugs increased significantly from 125.7G12.5 DID
before the pandemic to 158.3G25.7 DID during the pandemic (P! 0.001). There
was a considerable rise in the use of oral antidiabetics, with utilization increasing
from 71.2G6.9 DID prior to the pandemic to 90.6G17.2 DID (P! 0.001).
Moreover, insulins and their analogs were utilized more frequently during the
pandemic, rising from the pre-pandemic levels of 52.4G6.7 DID to 65.4G10.0
DID (P! 0.001). Marked increases were observed in the expenses for
antidiabetics, moving from 65.4G8.4 to 86.7G15.0 million Euros (P! 0.001).
These increments were noted both for oral antidiabetics (from 35.8G5.6 to
50.4G10.2 million Euros, P! 0.001) and insulins (from 27.1G3.7 to 33.4G5.7
million Euros, P! 0.001).
Conclusion
Our study demonstrated a surge in the utilization and expenditure of antidiabetics
in the two years of the COVID-19 pandemic in Turkey, compared to prepandemic levels. These results should be considered in evaluating the association
of COVID-19 infection with chronic diseases such as diabetes, as well as the
outcomes of interventions to facilitate access to drugs for extraordinary
circumstances.
Description
Keywords
Citation
VİZDİKLAR C., AYDIN V., TAZEGÜL G., AKICI A., \"Impact of COVID-19 pandemic on nationwide antidiabetic drug utilization\", 25th European Congress of Endocrinology, İstanbul, Türkiye, 13 - 16 Mayıs 2023, cilt.90, ss.709